Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (1831)
All Articles published online
|
Sep 21, 2009 (publication date) through Nov 22, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Schulz-Geske S, Erdmann K, Wong RJ, Stevenson DK, Schröder H, Grosser N. Molecular mechanism and functional consequences of lansoprazole-mediated heme oxygenase-1 induction. World J Gastroenterol 2009; 15(35): 4392-4401 [PMID: 19764090 DOI: 10.3748/wjg.15.4392] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v15/i35/4392.htm |
| Number | Citing Articles |
| 1 |
Toru Maruyama, Mitsuhiro Fukata, Koichi Akashi. Association of atrial fibrillation and gastroesophageal reflux disease: Natural and therapeutic linkage of the two common diseases. Journal of Arrhythmia 2019; 35(1): 43 doi: 10.1002/joa3.12125
|
| 2 |
Nahuai Badiola, Victor Alcalde, Albert Pujol, Lisa-Marie Münter, Gerd Multhaup, Alberto Lleó, Mireia Coma, Montserrat Soler-López, Patrick Aloy, Stephen D. Ginsberg. The Proton-Pump Inhibitor Lansoprazole Enhances Amyloid Beta Production. PLoS ONE 2013; 8(3): e58837 doi: 10.1371/journal.pone.0058837
|
| 3 |
Naoko Yamagishi, Yuta Yamamoto, Toshio Nishi, Takao Ito, Yoshimitsu Kanai, Wei Hsum Yap. Lansoprazole protects hepatic cells against cisplatin-induced oxidative stress through the p38 MAPK/ARE/Nrf2 pathway. PLOS ONE 2023; 18(6): e0287788 doi: 10.1371/journal.pone.0287788
|
| 4 |
Alaa Mohamed, Diego Ochoa Crespo, Gurleen Kaur, Ibtisam Ashraf, Mercedes Maria Peck, Ruchira Maram, Bilal Haider Malik. Gastroesophageal Reflux and Its Association With Atrial Fibrillation: A Traditional Review. Cureus 2020; doi: 10.7759/cureus.10387
|
| 5 |
Kenneth P. Chen, Joon Lee, Roger G. Mark, Mengling Feng, Leo A. Celi, Brian E. Malley, John Danziger. Proton pump inhibitor use is not associated with cardiac arrhythmia in critically ill patients. The Journal of Clinical Pharmacology 2015; 55(7): 774 doi: 10.1002/jcph.479
|
| 6 |
Lin Shi, Dan Zhang. Proton Pump Inhibitor Use Before ICU Admission Is Not Associated With Mortality of Critically Ill Patients. The Journal of Clinical Pharmacology 2020; 60(7): 860 doi: 10.1002/jcph.1585
|
| 7 |
Brian L. Le, Sota Iwatani, Ronald J. Wong, David K. Stevenson, Marina Sirota. Computational discovery of therapeutic candidates for preventing preterm birth. JCI Insight 2020; 5(3) doi: 10.1172/jci.insight.133761
|
| 8 |
Kun Lin, Xinpei Chen, Li Zhang, Yutang Wang, Zhaoliang Shan. Proton pump inhibitors as also inhibitors of atrial fibrillation. European Journal of Pharmacology 2013; 718(1-3): 435 doi: 10.1016/j.ejphar.2013.07.043
|
| 9 |
Tejal Gandhi, Anish Sharma, Navdha Vyas, Parth Gupta, Mihir Parikh, Hital Shah. Lansoprazole a Proton Pump Inhibitor Prevents IBD by Reduction of Oxidative Stress and NO Levels in the Rat. Drug Research 2021; 71(07): 379 doi: 10.1055/a-1389-5499
|
| 10 |
Yuji Naito, Tomohisa Takagi, Kazuhiko Uchiyama, Toshikazu Yoshikawa. Heme oxygenase-1: a novel therapeutic target for gastrointestinal diseases. Journal of Clinical Biochemistry and Nutrition 2011; 48(2): 126 doi: 10.3164/jcbn.10-61
|